Document type:
Correction; Published Erratum
Author(s):
Ohlmann, Carsten-Henning; Jäschke, Michelle; Jaehnig, Peter; Krege, Susanne; Gschwend, Jürgen; Rexer, Heidrun; Junker, Kerstin; Zillmann, Roger; Rüssel, Christoph; Hellmis, Eva; Suttmann, Henrik; Janssen, Martin; Marin, Jan; Hübner, Andreas; Mathers, Michael; Gleißner, Jochen; Scheffler, Michael; Feyerabend, Susan; Telle, Jens; Klier, Jörg; Stöckle, Michael
Title:
Correction to: LHRH sparing therapy in patients with chemotherapy-naïve, mCRPC treated with abiraterone acetate plus prednisone: results of the randomized phase II SPARE trial.
Journal title abbreviation:
Prostate Cancer Prostatic Dis
Year:
2023
Journal volume:
26
Journal issue:
4
Fulltext / DOI:
doi:10.1038/s41391-023-00682-2
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/37253975
Print-ISSN:
1365-7852
TUM Institution:
Klinik und Poliklinik für Urologie (Prof. Gschwend)
BibTeX